Liesbeth Van Hijfte

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell et al. · JAMA Neurology · 2023 · 55 citations · Full text

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Charles B. Malpas, Emmanuelle Leray et al. · Neurology · 2022 · 44 citations · Full text

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Tomáš Kalinčík, Sifat Sharmin, Izanne Roos et al. · JAMA Neurology · 2023 · 44 citations · Full text

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis

Marianna Vitková, Ibrahima Diouf, Charles B. Malpas et al. · Neurology · 2022 · 31 citations · Full text

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation

Chao Zhu, Tomáš Kalinčík, Dana Horáková et al. · JAMA Neurology · 2023 · 31 citations · Full text